Valuation: Perrigo Company plc

Market Cap 2.01B 36.53B 1.79B 1.67B 1.52B 2.86B 195B 2.89B 20.06B 7.85B 99.25B 7.55B 7.39B 318B P/E 2026 *
1,450x
P/E 2027 * 12.1x
Enterprise Value 4.92B 89.26B 4.38B 4.09B 3.72B 6.99B 476B 7.06B 49.01B 19.19B 243B 18.45B 18.06B 776B EV / Sales 2026 *
1.21x
EV / Sales 2027 * 1.17x
Free-Float
99.61%
Yield 2026 *
7.98%
Yield 2027 * 8.18%
3 years 557.52
Extreme 557.52
557.52
5 years 557.52
Extreme 557.52
852.8
10 years 557.52
Extreme 557.52
1,299.45
Manager TitleAgeSince
Chief Executive Officer 63 2026-06-06
Director of Finance/CFO 51 2022-05-15
Chief Operating Officer - 2025-06-22
Director TitleAgeSince
Director/Board Member 75 2014-10-31
Director/Board Member 61 2016-11-06
Director/Board Member 70 2017-02-05
Change 5-day change 1-year change 3-year change Capi.($)
-18.73%-.--% - - 2.02B
-1.61%+1.08%+38.64%+106.93% 1,060B
-0.76%-3.12%+35.78%+62.70% 623B
+0.39%+4.14%+17.00%+83.77% 480B
-0.29%-2.02%+62.52%+37.06% 352B
-2.03%+1.03%+22.25%+42.16% 345B
-1.92%-1.87%+11.94%+33.20% 274B
-2.36%-3.16%-6.95%+8.68% 249B
-1.37%-3.34%+37.86%+52.33% 223B
+0.17%-1.31%+25.96%+96.82% 182B
Average -3.06%-0.48%+27.22%+58.18% 420.89B
Weighted average by Cap. -0.96%+0.04%+30.57%+68.82%

Financials

2026 *2027 *
Net sales 4.06B 73.7B 3.62B 3.37B 3.07B 5.77B 393B 5.83B 40.46B 15.84B 200B 15.24B 14.91B 641B 4.09B 74.24B 3.65B 3.4B 3.09B 5.82B 396B 5.88B 40.76B 15.96B 202B 15.35B 15.02B 646B
Net income -224M -4.07B -200M -186M -169M -319M -21.69B -322M -2.23B -874M -11.05B -841M -823M -35.38B -56.95M -1.03B -50.79M -47.34M -43.04M -80.99M -5.51B -81.82M -568M -222M -2.81B -214M -209M -8.99B
Net Debt 2.9B 52.73B 2.59B 2.41B 2.2B 4.13B 281B 4.17B 28.95B 11.33B 143B 10.9B 10.67B 459B 2.78B 50.54B 2.48B 2.31B 2.1B 3.96B 269B 4B 27.75B 10.86B 137B 10.45B 10.22B 439B
Projected Income Statement - Annual - Perrigo Company plc
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Trader
Investor
Global
Quality
ESG MSCI
BB
Ratings Surperformance© - Perrigo Company plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
14.50USD
Average target price
16.50USD
Spread / Average Target
+13.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Perrigo Company plc